Clinical Trials on Acute Coronary Syndromes in New Zealand

Total 5690 results

National University Heart Centre, Singapore
AstraZeneca

Recruiting

PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (PASSIVATE)

Acute Coronary Syndrome

Australia, New Zealand, Singapore
NYU Langone Health
Doris Duke Charitable Foundation

Active, not recruiting

Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease (SWAN)

Acute Coronary Syndromes

United States
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark
Medstar Health Research Institute
GlaxoSmithKline

Completed

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)

Acute Coronary Syndromes

United States, Canada
AstraZeneca

Completed

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

Acute Coronary Syndromes

United States, Costa Rica, Panama, El Salvador, Morocco
Cerenis Therapeutics, SA
South Australian Health and Medical Research Institute

Completed

CER-001 Atherosclerosis Regression ACS Trial (CARAT)

Acute Coronary Syndromes

United States, Australia, Netherlands, Hungary
AstraZeneca

Completed

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Acute Coronary Syndromes

United States
Bristol-Myers Squibb
Pfizer; Duke Clinical Research Institute

Completed

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Acute Coronary Syndromes

Australia, Germany, Poland, United States, Spain, Brazil, France, Netherlands, Argentina, Mexico, Russian Federation, Colombia, Austria, Belgium, Czechia, Hungary, Israel, Peru, Switzerland, Korea, Republic of, Canada, Romania, Sweden, Ukrai... and more
New York State Psychiatric Institute
National Alliance for Research on Schizophrenia and Depression

Terminated

A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease (CHIME)

Depression | Coronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS)

United States
Biosite

Completed

Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

Acute Coronary Syndrome (ACS)

United States
Sanofi
Bristol-Myers Squibb

Completed

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction (CLARITY-TIMI28)

Acute Coronary Syndromes

Russian Federation, Belgium, Brazil, France, Germany, Hungary, Italy, Mexico, Netherlands, South Africa, Spain, Sweden, United States, Argentina, Australia, Ireland, Israel, Turkey, Austria, Poland, Canada, Portugal, Puerto Rico, United...
Medtronic Vascular

Completed

Bare Metal Bifurcation Stent Clinical Trial in Humans (BRANCH)

Myocardial Ischemia | Coronary Artery Disease

New Zealand
Novartis
The TIMI Study Group

Completed

Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome

Myocardial Ischemia | Post Acute Coronary Syndrome

Germany, Spain, United States, Belgium, Canada, Czech Republic, Hungary, Netherlands, Poland, Russian Federation, Sweden
PAVmed Inc.

Completed

PAVmed CarpX Device Clinical Study

Carpal Tunnel Syndrome

New Zealand
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
SB Technology, Inc.

Recruiting

MCG Discovery Study in Emergency Departments

NSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary Syndrome

United States
Stony Brook University
Hennepin County Medical Center, Minneapolis

Unknown

EKG Criteria and Identification of Acute Coronary Occlusion

Acute Coronary Syndrome | STEMI | NSTEMI - Non-ST Segment Elevation MI | Non ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Coronary Artery Thrombosis (Diagnosis) | Non ST Segment Elevation Acute Coronary Syndrome and other conditions

United States
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Ortho-Clinical Diagnostics, Inc.

Unknown

VITROS Immunodiagnostic Products hs Troponin I

Myocardial Infarction | Acute Coronary Syndrome (ACS)

United States
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Coronary Artery Disease

New Zealand, Belgium
Fisher and Paykel Healthcare

Terminated

Toffee Full Face and Toffee Nasal Mask Evaluation in Obesity Hypoventilation Syndrome (NZ)

Obesity Hypoventilation Syndrome

New Zealand
OrbusNeich
Duke Clinical Research Institute; OrbusNeich Medical K.K.

Completed

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (HARMONEE)

Coronary Arteriosclerosis | Non ST Segment Elevation Acute Coronary Syndrome

United States, Japan
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Medicure
SCRI Development Innovations, LLC

Completed

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention (SAVI-PCI)

Myocardial Infarction | Unstable Angina | Acute Coronary Syndromes

United States
VA Office of Research and Development
NYU Langone Health

Completed

Colchicine in Percutaneous Coronary Intervention (Colchicine-PCI)

Coronary Artery Disease | Acute Coronary Syndrome

United States
University of Auckland, New Zealand

Completed

MIld to MOderate Acute Pancreatitis: Early naSogastric Tube Feeding Compared With pAncreas Rest (MIMOSA) (MIMOSA)

Acute Pancreatitis

New Zealand
National Cancer Institute (NCI)

Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditions

United States, Canada, New Zealand
University of Auckland, New Zealand

Completed

Patient-Initiated and ConTrolled Oral Refeeding (PICTOR) (PICTOR)

Acute Pancreatitis

New Zealand
Regado Biosciences, Inc.

Completed

A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome (RADAR)

Acute Coronary Syndrome (ACS)

United States, Canada, Germany, France
Otsuka Australia Pharmaceutical Pty Ltd

Recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia (PREFER-HMA)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient Preference

New Zealand, Australia
University Hospital, Essen

Completed

Epicardial Adipose Tissue Thickness PredIcts Obstructive Coronary Artery Disease in Acute Coronary Syndrome Patients (EPIC-ACS)

Acute Coronary Syndrome

Germany
University of Auckland, New Zealand

Withdrawn

Oral Refeeding IntOlerance After Nasogastric Tube Feeding (ORION) (ORION)

Acute Pancreatitis

New Zealand
Elixir Medical Corporation

Completed

DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

Coronary Artery Disease

New Zealand
Kures, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults

Acute Pain

New Zealand
Bristol-Myers Squibb

Completed

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Acute Coronary Syndrome (ACS)

Canada, Italy, Poland, Sweden, United States, Spain, Austria, Denmark, France, Belgium, Israel, Germany, Russian Federation, United Kingdom
Angel Medical Systems
Symbios Clinical

Completed

AngelMed for Early Recognition and Treatment of STEMI (ALERTS)

Acute Coronary Syndrome | Coronary Occlusion | Acute Myocardial Infarction (AMI)

United States
Fisher and Paykel Healthcare

Terminated

Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing

Sleep Apnea, Obstructive | Obesity Hypoventilation Syndrome

New Zealand
Northwell Health
Toshiba America Medical Systems, Inc.

Enrolling by invitation

The Value of CT-FFR Compared to CCTA or CCTA and Stress MPI in Low to Intermediate Risk ED Patients With Toshiba CT-FFR

Coronary Artery Disease | Chest Pain | Acute Coronary Syndrome | Acute Myocardial Infarction

United States
Columbia University
Roche Pharma AG

Completed

5th Generation cTnT in ED ACS

Acute Coronary Syndrome

United States
Winthrop University Hospital

Terminated

Effects of Standard Treatment of Acute Coronary Syndromes on Macrophage Activity as Measured by Serum Neopterin

Acute Coronary Syndrome

United States
Micell Technologies

Completed

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)

Coronary Artery Disease

Belgium, Australia, New Zealand
Eli Lilly and Company

Completed

Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients

Acute Coronary Syndrome

India
Far Eastern Memorial Hospital
National Taiwan University Hospital

Active, not recruiting

Magnetic Nanoparticles System in Acute Coronary Syndrome

Acute Coronary Syndrome

Taiwan
St. Luke's-Roosevelt Hospital Center

Completed

ProspEctive First Evaluation in Chest Pain Trial (PERFECT)

Chest Pain | Shortness of Breath | Suspected Acute Coronary Syndrome

United States
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
AstraZeneca
Duke Clinical Research Institute

Completed

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS)

Cost Sharing, Acute Coronary Syndrome

United States, Puerto Rico
GlaxoSmithKline

Completed

Phase I Study of GW856553 (Losmapimod)

Acute Coronary Syndrome

Australia
Tallikut Pharmaceuticals, Inc.
Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University... and other collaborators

Completed

Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event

Acute Coronary Syndrome

United States
University of Auckland, New Zealand
Auckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...

Completed

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene (PCOSMIC)

Polycystic Ovary Syndrome

New Zealand
Memorial Sloan Kettering Cancer Center

Completed

Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

Myelodysplastic Syndromes (MDS) | Acute Myelogenous Leukemia (AML)

United States

Clinical Trials on Acute Coronary Syndromes in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations